Market Cap 3.60M
Revenue (ttm) 0.00
Net Income (ttm) -17.80M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 751,300
Avg Vol 3,704,934
Day's Range N/A - N/A
Shares Out 6.66M
Stochastic %K 10%
Beta 2.37
Analysts Strong Buy
Price Target N/A

Latest News on CDT

Conduit Pharmaceuticals Announces Leadership Changes

Apr 16, 2025, 8:30 AM EDT - 9 days ago

Conduit Pharmaceuticals Announces Leadership Changes


Conduit Progresses Phase II of its AI Initiative with Sarborg

Feb 20, 2025, 8:00 AM EST - 2 months ago

Conduit Progresses Phase II of its AI Initiative with Sarborg


Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

Jan 23, 2025, 8:00 AM EST - 3 months ago

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split